LubioSciences and IDT launch new longer e-Blocks Gene Fragments for antibody discovery

E-Blocks Gene Fragments are uniquely suited for high-throughput screening (HTS), especially for antibody discovery workflows. They allow for convenient cloning of the antibody of choice and are also useful for a variety of in vitro selection techniques like phage display.

The new longer e-Blocks Gene Fragments are up to 1500 bp in length. This increase in length allows researchers to generate larger libraries of more complex antibody fragments, which may result in the discovery of higher-affinity antibodies with greater specificity.

“We are thrilled to offer our customers access to longer e-Blocks from IDT," says Dr. Muriel Revol, Director of Custom Services. "This is a significant improvement over the previous e-Blocks technology and will enable researchers to accelerate their antibody discovery efforts even further."

IDT’s e-Blocks technology is based on their industry-leading oligonucleotide synthesis platform, which ensures high quality and consistency across batches. The technology is also scalable, allowing researchers to generate libraries of any size.